Issue of Shares

AIM Announcement 19 May 2025

Wellnex Life Limited (ASX/AIM:WNX)

Issue of Shares

Wellnex Life Limited ("Wellnex" or the "Company") (ASX/AIM:WNX), an innovative consumer healthcare business with a track record for developing, licensing, and marketing products and brands to customers in the growing healthcare market segment, announces that it has issued 646,153 new ordinary shares of no par value each in the Company ("Ordinary Shares") at a reference price of A$0.65 per share, in settlement of fees in respect of an undertaking provided by Barclay Pearce Capital Investment Pty Limited to the Company at the time of its admission to AIM.

Further details in respect of the undertaking are set out in the Company's Admission Document.

Admission and Total Voting Rights

Application has been made to the London Stock Exchange for admission of the 646,153 Ordinary Shares to trading on AIM. It is expected that admission will become effective and dealings in the Ordinary Shares will commence on AIM at 8.00 a.m. on or around 22 May 2025.

The new Ordinary Shares will be issued fully paid and will rank pari passu in all respects with the Company's existing Ordinary Shares.

Following Admission, the Company's issued share capital will comprise of 67,771,528 Ordinary Shares, none of which are held in treasury. Accordingly, the figure of 67,771,528 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules and the provisions of the Company's constitution.

This AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).

For further information, please contact:

Wellnex Life Limited (ASX:WNX) Reach Markets

George Karafotias or Zack Bozinovski T: 1300 805 9419

Joint Chief Executive Officers E: [email protected]

P: +61 3 8399 9419

E: [email protected]

UK Investors

Strand Hanson (Financial & Nominated Advisor)

James Harris / Richard Johnson / Robert Collins Tel: +44 (0) 20 7409 3494

Orana Corporate LLP (Joint Broker) [email protected]

Sebastian Wykeham

S.P. Angel Corporate Finance LLP (Joint Broker) Tel: +44 (0)20 3470 0470

David Hignell / Vadim Alexandre